Sharon Smith

A US-based phase 2 trial of an investigational oral GLP-1 called CX11 shows up to 11.5% weight loss and a favorable safety profile among patients living with obesity. Medscape Medical News source https://www.medscape.com/viewarticle/positive-phase-2-results-new-oral-glp-1-obesity-2026a1000mpj?src=rss

Experts recommend individualized VTE prevention for travelers at increased risk, emphasizing movement, hydration, compression stockings, and selective anticoagulant use. Medscape News Europe source https://www.medscape.com/viewarticle/air-travel-and-venous-thromboembolism-who-risk-2026a1000mll?src=rss

For patients who receive heart-sparing radiotherapy for breast cancer, coronary artery dose is key in the risk for future cardiac events. Medscape Medical News source https://www.medscape.com/viewarticle/breast-rt-coronary-artery-dose-better-predicts-cardiac-risk-2026a1000mli?src=rss

Emerging evidence suggests that gut biotics may help reduce inflammation and improve psoriasis severity, but larger studies are still needed before routine clinical use. Medscape News Europe source https://www.medscape.com/viewarticle/psoriasis-can-gut-biotics-improve-treatment-2026a1000mha?src=rss

In adults with overweight or obesity using tirzepatide for at least 12 months, women lost more weight, but age was not a predictor. Medscape Medical News source https://www.medscape.com/viewarticle/tirzepatide-weight-loss-greater-women-vs-men-age-no-link-2026a1000mh5?src=rss

Prescribing practices for immunosuppressive therapy in limited cutaneous systemic sclerosis vary among rheumatologists, especially when managing skin or subclinical organ involvement. Medscape Medical News source https://www.medscape.com/viewarticle/prescribing-limited-cutaneous-systemic-sclerosis-who-gets-2026a1000maf?src=rss